{"log_id": 7043393726196328738, "direction": 0, "words_result_num": 58, "words_result": [{"probability": {"variance": 0.000239, "average": 0.991737, "min": 0.947016}, "location": {"width": 181, "top": 144, "height": 21, "left": 134}, "words": "准日期:2006年10月16"}, {"probability": {"variance": 0, "average": 0.999801, "min": 0.999497}, "location": {"width": 83, "top": 143, "height": 24, "left": 879}, "words": "注册商标"}, {"probability": {"variance": 2e-06, "average": 0.998395, "min": 0.995599}, "location": {"width": 157, "top": 163, "height": 26, "left": 166}, "words": "期:2016年10月31日"}, {"probability": {"variance": 4.3e-05, "average": 0.997169, "min": 0.972249}, "location": {"width": 661, "top": 222, "height": 49, "left": 217}, "words": "重组人粒细胞刺激因子注射液说明书"}, {"probability": {"variance": 4e-06, "average": 0.997464, "min": 0.995145}, "location": {"width": 102, "top": 265, "height": 25, "left": 499}, "words": "瑞血新"}, {"probability": {"variance": 2e-06, "average": 0.998779, "min": 0.994154}, "location": {"width": 289, "top": 297, "height": 27, "left": 406}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 1e-06, "average": 0.999289, "min": 0.998142}, "location": {"width": 109, "top": 336, "height": 26, "left": 125}, "words": "【药品名称】"}, {"probability": {"variance": 6e-06, "average": 0.997771, "min": 0.991342}, "location": {"width": 353, "top": 359, "height": 30, "left": 121}, "words": "通用名称:重组人粒细胞刺激因子注射液"}, {"probability": {"variance": 0, "average": 0.999688, "min": 0.998828}, "location": {"width": 159, "top": 389, "height": 25, "left": 120}, "words": "商品名称:瑞血新"}, {"probability": {"variance": 0, "average": 0.99957, "min": 0.998971}, "location": {"width": 81, "top": 416, "height": 22, "left": 121}, "words": "英文名称"}, {"probability": {"variance": 0.005931, "average": 0.921541, "min": 0.844529}, "location": {"width": 14, "top": 417, "height": 16, "left": 331}, "words": "Hu"}, {"probability": {"variance": 0, "average": 0.971284, "min": 0.971284}, "location": {"width": 17, "top": 416, "height": 14, "left": 392}, "words": " Gr"}, {"probability": {"variance": 0.000128, "average": 0.994594, "min": 0.969342}, "location": {"width": 154, "top": 442, "height": 22, "left": 122}, "words": "汉语拼音: Chong"}, {"probability": {"variance": 1.8e-05, "average": 0.936581, "min": 0.932318}, "location": {"width": 79, "top": 440, "height": 20, "left": 388}, "words": " Cijiyinzi Zh"}, {"probability": {"variance": 3.9e-05, "average": 0.993306, "min": 0.985683}, "location": {"width": 66, "top": 466, "height": 22, "left": 128}, "words": "【成份】"}, {"probability": {"variance": 0.000138, "average": 0.995702, "min": 0.925452}, "location": {"width": 859, "top": 479, "height": 41, "left": 122}, "words": "活性成份:重组人粒细胞刺激因子,系由高效表达人粒细胞集落刺激因子(简称人粒细胞刺激因子)基"}, {"probability": {"variance": 1e-06, "average": 0.999178, "min": 0.996974}, "location": {"width": 415, "top": 511, "height": 35, "left": 121}, "words": "因的大肠杆菌,经发酵、分离和高度纯化后获得"}, {"probability": {"variance": 1e-06, "average": 0.999314, "min": 0.996709}, "location": {"width": 436, "top": 539, "height": 27, "left": 123}, "words": "药用辅料:甘露醇、冰醋酸、醋酸钠、聚山梨酯80"}, {"probability": {"variance": 2e-06, "average": 0.998287, "min": 0.996618}, "location": {"width": 66, "top": 570, "height": 23, "left": 131}, "words": "【性状】"}, {"probability": {"variance": 0, "average": 0.999539, "min": 0.997996}, "location": {"width": 157, "top": 593, "height": 22, "left": 125}, "words": "应为无色澄明液体"}, {"probability": {"variance": 0, "average": 0.999576, "min": 0.99932}, "location": {"width": 87, "top": 621, "height": 21, "left": 131}, "words": "【适应症】"}, {"probability": {"variance": 6.9e-05, "average": 0.997326, "min": 0.946247}, "location": {"width": 833, "top": 631, "height": 40, "left": 123}, "words": "1癌症化疗等原因导致中性粒细胞减少症。癌症患者使用骨髓抑制性化疗药物,特别在强烈的骨髓"}, {"probability": {"variance": 6e-06, "average": 0.998956, "min": 0.984947}, "location": {"width": 818, "top": 658, "height": 38, "left": 124}, "words": "剥夺性化学药物治疗后,注射本品有助于预防中性粒细胞减少症的发生,减轻中性粒细胞减少的"}, {"probability": {"variance": 6e-06, "average": 0.998487, "min": 0.988201}, "location": {"width": 797, "top": 685, "height": 36, "left": 125}, "words": "程度,缩短粒细胞缺乏症的持续时间,加速粒细胞数的恢复,从而减少合并感染发热的危险性"}, {"probability": {"variance": 6.4e-05, "average": 0.996232, "min": 0.966002}, "location": {"width": 330, "top": 717, "height": 30, "left": 125}, "words": "2促进骨髓移植后的中性粒细胞数升高"}, {"probability": {"variance": 4.4e-05, "average": 0.997796, "min": 0.961828}, "location": {"width": 839, "top": 734, "height": 40, "left": 125}, "words": "3骨髓发育不良综合征引起的中性粒细胞减少症;再生障碍性贫血引起的中性粒细胞减少症;先天性"}, {"probability": {"variance": 2.2e-05, "average": 0.998012, "min": 0.978962}, "location": {"width": 817, "top": 762, "height": 37, "left": 126}, "words": "特发性中性粒细胞减少症;骨髓增生异常综合征伴中性粒细胞减少症;周期性中性粒细胞减少症"}, {"probability": {"variance": 1e-06, "average": 0.998804, "min": 0.997928}, "location": {"width": 68, "top": 799, "height": 24, "left": 133}, "words": "【规格】"}, {"probability": {"variance": 0.006118, "average": 0.96767, "min": 0.563123}, "location": {"width": 780, "top": 814, "height": 38, "left": 125}, "words": "75μg/0.3ml/支、100μg/0.4ml/支、125μg/0.5m/支、150μg/0.6ml/支、200μg/0.8ml/支"}, {"probability": {"variance": 0.000905, "average": 0.985084, "min": 0.89418}, "location": {"width": 143, "top": 849, "height": 24, "left": 128}, "words": "300μg/1.2m/支"}, {"probability": {"variance": 1.7e-05, "average": 0.995324, "min": 0.988986}, "location": {"width": 105, "top": 875, "height": 25, "left": 135}, "words": "【用法用量】"}, {"probability": {"variance": 1.1e-05, "average": 0.998143, "min": 0.982111}, "location": {"width": 855, "top": 890, "height": 38, "left": 130}, "words": "化疗药物给药结束后24~48小时起皮下或静脉注射本品,每日1次。本品的用量和用药时间应根据患"}, {"probability": {"variance": 0.001617, "average": 0.989267, "min": 0.76867}, "location": {"width": 857, "top": 914, "height": 40, "left": 129}, "words": "者化疗的强度和中性粒细胞下降程度决定。对化疗强度较大或粒细胞下降较明显的患者以2.5μg/k"}, {"probability": {"variance": 6.6e-05, "average": 0.99721, "min": 0.95048}, "location": {"width": 864, "top": 940, "height": 43, "left": 125}, "words": "体重/日的剂量连续用药7天以上较为适宜,至中性粒细胞恢复至5000/mm3停药;如所用化疗药物的"}, {"probability": {"variance": 0.007286, "average": 0.9809, "min": 0.535619}, "location": {"width": 850, "top": 969, "height": 38, "left": 128}, "words": "剂量较低,估计所造成的骨髓抑制不太严重者,可考虑使用较低剂量预防中性粒细胞减少,以1.25μ"}, {"probability": {"variance": 0.000645, "average": 0.992391, "min": 0.84891}, "location": {"width": 853, "top": 992, "height": 40, "left": 131}, "words": "gkg体重/日的剂量用药至中性粒细胞数稳定于安全范围,对化疗后中性粒细胞已明显降低的患者(中"}, {"probability": {"variance": 0.000193, "average": 0.993323, "min": 0.94949}, "location": {"width": 248, "top": 1028, "height": 28, "left": 131}, "words": "性粒细胞数<1000/mm3),以"}, {"probability": {"variance": 0.00058, "average": 0.991258, "min": 0.875742}, "location": {"width": 835, "top": 1043, "height": 40, "left": 133}, "words": "5μg/kg体重/日的剂量用药至中性粒细胞数恢复至5000/m3以上,稳定后终止本品治疗并监视病情"}, {"probability": {"variance": 0.000411, "average": 0.986445, "min": 0.951493}, "location": {"width": 55, "top": 1085, "height": 20, "left": 130}, "words": "1.肿瘤"}, {"probability": {"variance": 0.000409, "average": 0.991759, "min": 0.8949}, "location": {"width": 858, "top": 1093, "height": 40, "left": 129}, "words": "用于化疗所致的中性粒细胞减少症等。成年患者化疗后中性粒细胞数降至1000/m3(白细胞计数"}, {"probability": {"variance": 0.001499, "average": 0.983761, "min": 0.840119}, "location": {"width": 854, "top": 1122, "height": 37, "left": 133}, "words": "2000/mm3)以下者,在开始化疗后,2~5μg/kg每日1次皮下或静脉注射给药。儿童患者化疗后中性"}, {"probability": {"variance": 0.000253, "average": 0.992729, "min": 0.911773}, "location": {"width": 857, "top": 1146, "height": 39, "left": 132}, "words": "粒细胞数降至500/mm3(白细胞计数1000/m3)以下者,在开始化疗后,2~5μg/kg每日1次皮下或"}, {"probability": {"variance": 0.000411, "average": 0.990455, "min": 0.900659}, "location": {"width": 790, "top": 1173, "height": 37, "left": 131}, "words": "静脉注射给药。当中性粒细胞数回升至5000/mm3(白细胞计数10000/m3)以上时,停止给药"}, {"probability": {"variance": 0, "average": 0.999389, "min": 0.997488}, "location": {"width": 368, "top": 1205, "height": 30, "left": 133}, "words": "2急性白血病化疗所致的中性粒细胞减少症"}, {"probability": {"variance": 2e-06, "average": 0.998886, "min": 0.994568}, "location": {"width": 346, "top": 1232, "height": 29, "left": 133}, "words": "白血病患者化疗后白细胞计数不足1000"}, {"probability": {"variance": 4e-06, "average": 0.998514, "min": 0.99132}, "location": {"width": 440, "top": 1222, "height": 32, "left": 540}, "words": "骨髓中的原粒细胞明显减少,外周血液中未见原粒"}, {"probability": {"variance": 4.7e-05, "average": 0.996782, "min": 0.965556}, "location": {"width": 856, "top": 1248, "height": 40, "left": 135}, "words": "胞的情况下,成年患者2~5μg/kg每日1次皮下或静脉注射给药;儿童患者2μg/kg每日1次皮下或"}, {"probability": {"variance": 0.004278, "average": 0.969747, "min": 0.679675}, "location": {"width": 789, "top": 1276, "height": 37, "left": 134}, "words": "静脉注射给药。当中性粒细胞数回升至5000/mm3(白细胞计数1000/m3)以上时,停止给药"}, {"probability": {"variance": 2e-06, "average": 0.998791, "min": 0.994651}, "location": {"width": 367, "top": 1308, "height": 30, "left": 134}, "words": "3骨髓增生异常综合征伴中性粒细胞减少症"}, {"probability": {"variance": 0.001348, "average": 0.987135, "min": 0.771244}, "location": {"width": 853, "top": 1325, "height": 41, "left": 139}, "words": "成年患者在其中性粒细胞不足100/mm3时,2~5μg/kg每日1次皮下或静脉注射给药。中性粒细胞"}, {"probability": {"variance": 0.001518, "average": 0.977234, "min": 0.857772}, "location": {"width": 333, "top": 1359, "height": 32, "left": 135}, "words": "数回升至5000/m3以上时,停止给药"}, {"probability": {"variance": 0.000998, "average": 0.99157, "min": 0.857707}, "location": {"width": 348, "top": 1387, "height": 27, "left": 134}, "words": "4.再生障碍性贫血所致中性粒细胞减少症"}, {"probability": {"variance": 0.000428, "average": 0.991914, "min": 0.899914}, "location": {"width": 856, "top": 1402, "height": 41, "left": 136}, "words": "成年患者在其中性粒细胞低于1000/m3时,2~5μg/kg每日1次皮下或静脉注射给药。中性粒细胞"}, {"probability": {"variance": 0.008337, "average": 0.959282, "min": 0.705088}, "location": {"width": 129, "top": 1442, "height": 22, "left": 137}, "words": "数回升至5000/"}, {"probability": {"variance": 4.6e-05, "average": 0.997086, "min": 0.973764}, "location": {"width": 254, "top": 1435, "height": 29, "left": 312}, "words": "以上时,酌情减量或停止给药"}, {"probability": {"variance": 1e-06, "average": 0.999038, "min": 0.996429}, "location": {"width": 717, "top": 1456, "height": 36, "left": 135}, "words": "5周期性中性粒细胞减少症、自身免疫性中性粒细胞减少症和慢性中性粒细胞减少症"}, {"probability": {"variance": 0.001202, "average": 0.988617, "min": 0.821077}, "location": {"width": 854, "top": 1479, "height": 39, "left": 139}, "words": "成年患者中性粒细胞低于1000/m3时,1μg/kg每日1次皮下或静脉注射给药。儿童患者中性粒细胞"}, {"probability": {"variance": 0, "average": 0.999556, "min": 0.999487}, "location": {"width": 22, "top": 1585, "height": 23, "left": 536}, "words": "26"}], "language": 3}